Morphic Holding Stock

Morphic Holding Liabilities 2025

Morphic Holding Liabilities

25.49 M USD

Ticker

MORF

ISIN

US61775R1059

WKN

A2PLX9

In 2025, Morphic Holding's total liabilities amounted to 25.49 M USD, a 30.73% difference from the 19.5 M USD total liabilities in the previous year.

Morphic Holding Aktienanalyse

What does Morphic Holding do?

Morphic Holding Inc. is a pharmaceutical company that focuses on developing therapies for serious diseases. The company was founded in 2015 and is based in Waltham, Massachusetts. The company's business model is centered around developing drugs based on "Morphic Molecules" that are specifically designed to interact with certain target proteins in the body. These molecules aim to improve the treatment of diseases such as autoimmune diseases and fibrosis. Morphic Holding Inc. collaborates closely with leading scientists in the field of structural biology to develop new therapy options for patients. The company has formed partnerships with Biogen, Janssen Biotech, and AbbVie to collaboratively develop new medications. In addition to partnering with other leading companies in the healthcare industry, Morphic Holding Inc. also maintains its own research department focused on the discovery and development of new compounds. The company has applied for and been granted several patents for its "Morphic Molecules," further strengthening its ability to develop innovative therapies for serious diseases. One of Morphic Holding Inc.'s current products is a drug for the treatment of cystic fibrosis that is still in the development phase. The company is working to advance its research and development in this area to continue offering innovative therapies for patients. Morphic Holding Inc. is also involved in biotechnological development and offers services to assist other companies in developing new compounds. These services include the identification and validation of target proteins, the design and synthesis of molecules, and the optimization of drug properties. In conclusion, Morphic Holding Inc. is an emerging force in the pharmaceutical development field. The company has a unique approach to drug development and has already established partnerships with other companies and leading research institutions to develop new therapy options for patients. With its commitment to innovation and research, Morphic Holding Inc. is likely to continue making significant advancements in the field of medicine in the future. Morphic Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Morphic Holding's Liabilities

Morphic Holding's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Morphic Holding's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Morphic Holding's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Morphic Holding's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Morphic Holding’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Morphic Holding stock

What is the level of liabilities of Morphic Holding this year?

Morphic Holding has a debt balance of 25.49 M USD this year.

What were the liabilities of Morphic Holding compared to the previous year?

The liabilities of Morphic Holding have increased by 30.73% increased compared to the previous year.

What are the consequences of high debt for investors of Morphic Holding?

High liabilities can pose a risk for investors of Morphic Holding, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Morphic Holding?

Low liabilities mean that Morphic Holding has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Morphic Holding affect the company?

An increase in liabilities of Morphic Holding can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Morphic Holding affect the company?

A decrease in the liabilities of Morphic Holding can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Morphic Holding?

Some factors that can influence the liabilities of Morphic Holding include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Morphic Holding so important for investors?

The liabilities of Morphic Holding are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Morphic Holding take to modify the liabilities?

To change its liabilities, Morphic Holding can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Morphic Holding pay?

Over the past 12 months, Morphic Holding paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Morphic Holding is expected to pay a dividend of 0 USD.

What is the dividend yield of Morphic Holding?

The current dividend yield of Morphic Holding is .

When does Morphic Holding pay dividends?

Morphic Holding pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Morphic Holding?

Morphic Holding paid dividends every year for the past 0 years.

What is the dividend of Morphic Holding?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Morphic Holding located?

Morphic Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Morphic Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Morphic Holding from 8/3/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/3/2025.

When did Morphic Holding pay the last dividend?

The last dividend was paid out on 8/3/2025.

What was the dividend of Morphic Holding in the year 2024?

In the year 2024, Morphic Holding distributed 0 USD as dividends.

In which currency does Morphic Holding pay out the dividend?

The dividends of Morphic Holding are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Morphic Holding

Our stock analysis for Morphic Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Morphic Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.